Subject
PedPal Lit; 11; 2-4; 22; 26; 5-11; Adolescent Anticonvulsants/administration & dosage/adverse effects Child Child; and 12-17-year-old age groups; and 12-17-year-olds; and 33/1000 children chronically prescribed antiepileptic therapy in the 0-1; and six for the 0-1; ciprofloxacin; Computerized Polypharmacy Prescriptions; Drug/statistics & numerical data Primary Health Care/statistics & numerical data Research Support; erythromycin; Newborn Medical Records Systems; Non-U.S. Gov't Scotland%X AIMS: To investigate the extent of acute coprescribing in primary care to children on chronic antiepileptic therapy; Preschool Drug Administration ScheduleDrug Interactions Epilepsy/drug therapy Humans Infant Infant; respectively. Of these acute coprescriptions 72 (1.5%) prescribed to 22 (3.0%) children were identified as a potential source of clinically serious interactions. The age-adjusted prevalence rates for potentially serious coprescribing were 86; respectively. The drugs most commonly coprescribed which could give rise to such interactions were antacids; six; theophylline and (TRUNCATED); with carbamazepine